NDC 70377-012 – Everolimus
Everolimus 7.5 mg/1 · Tablet · Oral
Product NDC70377-012
Product details
- Brand name
- Everolimus
- Generic name
- Everolimus
- Labeler
- Biocon Pharma Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA214182
- Marketed since
- October 1, 2021
- Listing expires
- December 31, 2026
- Pharmacologic class
- Kinase Inhibitor; mTOR Inhibitor Immunosuppressant
Active ingredients
- Everolimus 7.5 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 70377-012-11 | 30 TABLET in 1 BOTTLE (70377-012-11) | Jun 8, 2023 |
| 70377-012-22 | 4 BLISTER PACK in 1 CARTON (70377-012-22) / 7 TABLET in 1 BLISTER PACK | Oct 1, 2021 |
| 70377-012-23 | 4 BLISTER PACK in 1 CARTON (70377-012-23) / 7 TABLET in 1 BLISTER PACK | May 17, 2024 |
Other Everolimus products
- 67877-718 Everolimus .25 mg/1 · Tablet · Ascend Laboratories, LLC
- 67877-719 Everolimus .5 mg/1 · Tablet · Ascend Laboratories, LLC
- 67877-721 Everolimus 1 mg/1 · Tablet · Ascend Laboratories, LLC
- 67877-720 Everolimus .75 mg/1 · Tablet · Ascend Laboratories, LLC
- 59651-933 Everolimus .75 mg/1 · Tablet · Aurobindo Pharma Limited
- 59651-931 Everolimus .25 mg/1 · Tablet · Aurobindo Pharma Limited
- 59651-934 Everolimus 1 mg/1 · Tablet · Aurobindo Pharma Limited
- 59651-932 Everolimus .5 mg/1 · Tablet · Aurobindo Pharma Limited
- 70377-013 Everolimus 10 mg/1 · Tablet · Biocon Pharma Inc.
- 70377-010 Everolimus 2.5 mg/1 · Tablet · Biocon Pharma Inc.
- 70377-011 Everolimus 5 mg/1 · Tablet · Biocon Pharma Inc.
- 70377-069 Everolimus .25 mg/1 · Tablet · Biocon Pharma Inc.